Table: AFC-HD Ams Life Science -Q1 group results

AFC-HD AMS Life Science Co

14/01/2026 06:32

Jan 14 (Reuters)- 
             AFC-HD Ams Life Science Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Nov 30, 2025        Nov 30, 2024     Aug 31, 2026 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               8.55                8.19             34.14    
                   (+4.4 pct)          (+20.7 pct)      (+4.5 pct)  
  Operating          771 mln             650 mln            2.55    
                   (+18.6 pct)         (+35.9 pct)      (+5.6 pct)  
  Recurring          739 mln             704 mln            2.45    
                   (+5.0 pct)          (+44.0 pct)      (+0.1 pct)  
  Net                522 mln             460 mln            1.46    
                   (+13.6 pct)         (+44.5 pct)      (+1.0 pct)  
  EPS               36.70 yen           32.70 yen       103.73 yen  
  EPS Diluted                           32.69 yen                   
  Ann Div                               34.00 yen        36.00 yen  
  -Q2 div                               16.00 yen        18.00 yen  
  -Q4 div                               18.00 yen        18.00 yen  
  
  NOTE - AFC-HD Ams Life Science Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2927.T